- Country: USA
- Summary: Service Agreement Biacore 8K+ Fullcare
- UST Ref No: 118550476
- Deadline: 10 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: NOI-NIAID-25-2253076
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate an other than full and open competition basis with Global Life Sciences (Cytiva) for a Fullcare service agreement for a Biacore 8K+.
The Vaccine Research Center-s Immuno Technology Section (ITS) within the National Institute of Allergy and Infectious Diseases (NIAID) is conducting research to develop vaccines and therapeutics for pathogens with pandemic potential (SARS-CoV, Nipah Virus) using a technique called surface plasmon resonance (SPR). The SPR instrument allows ITS to analyze specific immune responses following infection and vaccine induced immune response. This project will seek characterize the qualities of antibodies induced by vaccination or infection. This evaluation allows for the development of next generation vaccines and therapeutics and is used to support ongoing clinical trials evaluating vaccines for SARS-CoV-2 and Nipah virus, as well as evaluate new therapeutic monoclonal antibody candidates.
In this project, ITS has developed an assay that will assess the reactivity of vaccine-induced antibodies in a quantitative manner. This project uses a high-throughput SPR instrument, which requires preventative maintenance once a year and periodic maintenance by a technician trained specifically for this instrument. The ITS requires a FullCare Service Agreement for a Biocore 8K+ S/N: 29283382-2673827.
Capabilities statements must address the capability of providing a priority response equal to a direct contract/service agreement with the manufacturer. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable se... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINService Agreement Biacore 8K+ Fullcare - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Service Agreement Biacore 8K+ Fullcare. This tender is published on USARFP under UST Ref No: 118550476 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
